Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Amgn save search
Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition
Published: 2023-11-06 (Crawled : 16:00) - prnewswire.com
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.34%
H: 1.54%
C: 0.76%
cell
Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio
Published: 2023-11-03 (Crawled : 23:00) - prnewswire.com
BIIB | $190.805 -0.71% 870K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.594 2.2K
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ABEO | $7.7 -2.9% 170K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $263.24 -0.31% 760K
|
Health Technology
| Email alert
Add to watchlist
GBIO | $2.89 -3.02% 45K
|
Health Technology
| Email alert
Add to watchlist
ADAP | $0.8753 -11.32% 2.6M
|
Health Technology
| Email alert
Add to watchlist
AAPL | News S | $166.77 -0.73% 26M
|
Electronic Technology
| Email alert
Add to watchlist
NVS | News | $92.61 -0.51% 430K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.46 500K
|
Manufacturing
| Email alert
Add to watchlist
america therapy market
Key Players Such as AbbVie, Roche, and Amgen Dominate the Competitive Landscape of the Expanding Cytokine Market
Published: 2023-11-03 (Crawled : 01:00) - prnewswire.com
UCBJF | $126.05 100
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
UCBJY | $64.07 72K
|
Manufacturing
|
| O: 0.48%
H: 1.02%
C: 0.42%
TMO | News | $542.71 -0.83% 1.2M
|
Health Technology
|
| O: 2.32%
H: 0.0%
C: 0.0%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: 1.88%
H: 0.0%
C: 0.0%
TECH | $62.04 -1.1% 490K
|
Health Technology
|
| O: 2.71%
H: 4.38%
C: 3.18%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.72%
H: 0.76%
C: 0.5%
ABCM | $23.99 0.0% 7.4M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
market
AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: 0.5%
H: 2.69%
C: -0.09%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.94%
H: 1.82%
C: 1.25%
krystexxa blood show
SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
SWTX | $44.15 0.09% 180K
|
Health Technology
|
| O: 4.14%
H: 6.22%
C: 1.41%
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: 0.5%
H: 2.69%
C: -0.09%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.94%
H: 1.82%
C: 1.25%
business therapeutics financial results
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
Published: 2023-11-01 (Crawled : 20:00) - biospace.com/
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: -1.12%
H: 1.26%
C: -1.57%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.22%
H: 1.92%
C: 1.78%
pipeline
Biosimilars market size to increase by USD 42.22 billion | The regulatory landscape regarding therapeutic interchangeability across different countries is the market trend - Technavio
Published: 2023-11-01 (Crawled : 09:00) - prnewswire.com
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: 0.06%
H: 1.3%
C: 0.43%
BIIB | $190.805 -0.71% 870K
|
Health Technology
|
| O: 0.43%
H: 1.05%
C: 0.44%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.22%
H: 1.92%
C: 1.78%
market
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-31 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: -3.51%
BMY | $47.895 0.12% 4.6M
|
Health Technology
|
| O: 0.25%
H: 0.54%
C: 0.29%
XNCR | $19.0 -0.37% 120K
|
Health Technology
|
| O: -0.41%
H: 2.1%
C: 1.11%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 2.61%
H: 0.0%
C: 0.0%
REGN | $900.22 -0.11% 150K
|
Health Technology
|
| O: -0.33%
H: 0.92%
C: 0.61%
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: 0.14%
H: 0.68%
C: -0.32%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -2.77%
H: 0.6%
C: -0.07%
financial results
PacBio Announces Third Quarter 2023 Financial Results
Published: 2023-10-30 (Crawled : 20:00) - prnewswire.com
MMM | $91.63 0.74% 950K
|
Producer Manufacturing
|
| O: -0.04%
H: 2.34%
C: 1.64%
PACB | $1.455 3.93% 9.2M
|
Health Technology
|
| O: -5.34%
H: 0.59%
C: -8.17%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -2.77%
H: 0.6%
C: -0.07%
financial results
Increasing Prevalence of Laryngeal Cancer Fuels Growth in Laryngeal Cancer Therapeutics Market
Published: 2023-10-27 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
AZNCF | $140.15 560
|
Health Technology
|
| O: -1.1%
H: 0.18%
C: -1.98%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
AZN | $68.38 -0.22% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.13%
C: -1.99%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -0.28%
H: 0.15%
C: -2.74%
cancer therapeutics growth market
A large international study of migraine reveals new biological pathways for treatment
Published: 2023-10-26 (Crawled : 18:00) - biospace.com/
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -0.24%
H: 0.71%
C: -0.66%
international treatment migraine study
AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-25 (Crawled : 23:00) - biospace.com/
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -0.37%
H: 0.58%
C: -1.07%
financial results
Biosimilars market size to increase by USD 42.22 billion | Market driven by the notable price advantage of biosimilars compared to biologics - Technavio
Published: 2023-10-25 (Crawled : 03:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 0.4%
H: 1.29%
C: 1.29%
VTRS | $11.12 0.18% 1.1M
|
Health Technology
|
| O: -0.44%
H: 0.33%
C: -1.1%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.64%
H: 0.46%
C: -0.09%
ABBV | $165.54 0.78% 2.2M
|
Health Technology
|
| O: 0.65%
H: 0.54%
C: -0.58%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 1.43%
H: 0.64%
C: -0.09%
BIIB | $190.805 -0.71% 870K
|
Health Technology
|
| O: -0.88%
H: 0.34%
C: -1.27%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -0.37%
H: 0.58%
C: -1.07%
advantage market
AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND
Published: 2023-10-24 (Crawled : 20:00) - prnewswire.com
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: -2.79%
H: 2.0%
C: -0.98%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: -0.37%
H: 0.58%
C: -1.07%
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published: 2023-10-22 (Crawled : 16:20) - prnewswire.com
CCXI | $51.99 -0.04%
|
Health Technology
| Email alert
Add to watchlist
AMGN | $263.24 -0.31% 760K
|
Health Technology
| Email alert
Add to watchlist
BGNE S | $132.43 0.43% 79K
|
Health Technology
| Email alert
Add to watchlist
BEIGF | $14.29 -9.87% 2.1K
|
n/a
| Email alert
Add to watchlist
lumakras cancer plus
AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
Published: 2023-10-20 (Crawled : 12:00) - prnewswire.com
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: -1.33%
H: 5.87%
C: 5.53%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -0.64%
lung cancer cell
Global Acute Myeloid Leukemia (AML) Treatment Market Trends Analysis Report 2023-2028 - Personalized Medicine and Patient Advocacy Drive Opportunities
Published: 2023-10-20 (Crawled : 10:00) - prnewswire.com
ALPMF | News | $9.594 2.2K
|
Health Technology
|
| O: -4.45%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -3.95%
H: 0.0%
C: -0.72%
ALPMY | News | $9.46 500K
|
Manufacturing
|
| O: -2.89%
H: 3.67%
C: 2.85%
GSK | $39.2 -1.01% 1.2M
|
Health Technology
|
| O: 0.42%
H: 0.54%
C: 0.11%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -0.64%
report treatment global trends leukemia market
AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023
Published: 2023-10-19 (Crawled : 20:00) - prnewswire.com
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -0.64%
AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023
Published: 2023-10-16 (Crawled : 18:00) - biospace.com/
XNCR | $19.0 -0.37% 120K
|
Health Technology
|
| O: 0.0%
H: 1.49%
C: 0.53%
BGNE S | $132.43 0.43% 79K
|
Health Technology
|
| O: -3.15%
H: 2.37%
C: 0.45%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.14%
H: 1.16%
C: 0.84%
pipeline research
PacBio Announces Appointment of David Meline to Board of Directors
Published: 2023-10-16 (Crawled : 12:00) - prnewswire.com
ABBNY | News | $45.795 170K
|
n/a
|
| O: -0.57%
H: 0.88%
C: 0.41%
ABLZF | News | $45.744 1.5K
|
Producer Manufacturing
|
| O: -2.83%
H: 1.2%
C: -0.04%
HPQ | $27.56 -0.47% 2.7M
|
Electronic Technology
|
| O: 0.75%
H: 1.12%
C: 0.67%
GM | News | $42.14 -0.75% 6M
|
Consumer Durables
|
| O: 0.84%
H: 0.9%
C: 0.5%
MMM | $91.63 0.74% 950K
|
Producer Manufacturing
|
| O: 0.27%
H: 1.37%
C: 1.15%
PACB | $1.455 3.93% 9.2M
|
Health Technology
|
| O: -2.51%
H: 4.63%
C: 2.57%
MRNA | News S | $101.87 -1.52% 710K
|
Health Technology
|
| O: -3.05%
H: 1.42%
C: -3.53%
AMGN | $263.24 -0.31% 760K
|
Health Technology
|
| O: 0.14%
H: 1.16%
C: 0.84%
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.